The role of genetic factors in the etiology of the autistic spectrum of disorders has clearly been demonstrated. Ten chromosomal regions, on chromosomes 1p, 4p, 6q, 7q, 13q, 15q, 16p, 17q, 19q and 22q have potentially been linked to autism.
Infantile autism is characterized by impairments in reciprocal social communication, restricted and stereotyped patterns of interests and activities, and the presence of developmental abnormalities by 3 years of age. 9 On the basis of family and twin studies, infantile autism and other autistic spectrum of disorders like Asperger syndrome cosegregate in the same families and have a strong genetic component. 10 The prevalence of autism is ෂ4:10 000, yielding a sibling risk (s) of 50-100 times higher when compared to the population risk. 10 Molecular genetic investigations of the UBE3A gene and ␥-aminobutyric acid A receptor subunit gene (GABRB3) on chromosome 15q11-13, and in addition serotonin transporter gene (SLC6A4) on the chromosome 17q11-q12 have not given any evidence for their possible role in the etiology of autism. 4, [6] [7] [8] Three genome scans in autism have so far been published. [1] [2] [3] The first study included a British subgroup of 66 multiplex families and revealed several putative loci with multipoint maximum lod scores (MLS) Ͼ1, the most promising region being on chromosome 7q (multipoint MLS 3.55). 2 The second scan with 51 mixed European and North American families resulted in the most significant multipoint MLS (2.23) on chromosome 6q. 3 In the third screen of 139 mixed American families, a maximum multipoint LOD score of 2.15 was achieved.
1 Preliminary data on the fourth genomic screen suggest a susceptibility locus on chromosome 13q21. 5 Two genome scans performed so far identified overlapping regions on chromosomes 7q, 16p and 19p. 2, 3 No specific gene that predisposes to autism has so far been identified.
The replication studies are essential to distinguish true from false-positive linkage findings in different population materials. Given the evidence for genetic heterogeneity in autism we have targeted our studies to the isolated Finnish population. We have carried out segregation analysis of the markers on ten previously analyzed candidate regions in 17 multiplex families with autism. The markers providing the most significant evidence for linkage on each chromosomal region are included in our study. None of the ten previously reported candidate regions showed statistically significant evidence for linkage in 17 multiplex Finnish families ( Table 1 ). The slightly interesting region in the analysis was on the chromosome 1p with markers DIS1675 and D1S534 which show maximum lod scores of 0.87 and 0.76 respectively ( Table 1 ). The affected sib-pairs shared 70.5% and 60.6% of alleles IBD with markers D1S1675 and D1S534 respectively. These sharing proportions were roughly the same as the maximal IBD sharing of 65.6% near marker D1S1361 reported by Risch et al (1999) in 90 multiplex families. 1 Multipoint analysis on chromosome 1 did not give any additional information in our material (data not shown).
Based on the population history of Finland and the data about Finnish diseases, it is possible that different susceptibility genes cause autism among the Finns. This is supported by mutation analyses of BRCA1 and BRCA2 genes in the Finnish families which show that different mutation spectrum and different susceptibility genes cause breast cancer in the Finnish population. 12, 13 Furthermore, genome scans performed so far on multiple sclerosis, 14 schizophrenia, 15 hypertension 16 and familial combined hyperlipidemia 17 in complex disorders have revealed candidate loci, some of which might have a stronger effect in the Finnish population than in more mixed populations. It has been hypothesized that a large number of gene loci predispose to autism. 1 The ongoing genome scan will hopefully reveal new susceptibility loci, which might add to our understanding about the genetics of autism. We are also examining the chromosome 1p region more closely with an extended family material.
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Methods
Family material
We recruited 17 multiplex Finnish families consisting of 14 sibling pair core families and three families with more remote consanguinity. Infantile autism was aggregating in eleven, and Asperger syndrome and autism in six families. Thorough clinical and medical examinations were performed by using the Childhood Autism Rating Scale (CARS), Asperger Syndrome Screening Questionnaire (ASSQ), and Asperger's Syndrome Diagnostic Interview (ASDI) 18 as screening instruments. Diagnoses were made according to the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) or ICD-10 criteria. 19 Families with associative medical conditions such as fragile-X syndrome, chromosomal aberrations, and neurocutaneous syndromes were excluded.
These studies have been approved by the ethical committees of the Hospital for Children and Adolescents of Helsinki University Hospital and National Public Health Institute, Helsinki. Informed consent was obtained from the subjects and/or their parents.
Genotyping DNA was extracted from EDTA blood according to standard procedures. The sequences of the polymorphic microsatellite markers were obtained from the Genome Database (http:gdbwww.gdb.org). The locations and the intermarker distances were derived from the genetic maps of Généthon (http:www.genethon. fr/genethon en.html) and the Genetic Location Database (http:cedar.genetics.soton.ac.uk/public html/index.html).
Statistical analysis
DNA from all family members were used for the analyses. Two-point pairwise linkage analysis was performed under a recessive model using the MLINK program of the LINKAGE package. 20, 21 An affecteds-only strategy was employed to minimize the effect of penetrance assumptions, since the true mode of inheritance is unknown. Nonparametric sib-pair analysis was performed using the SIBPAIR program. 22 
